I Dervite, D Hober, P Morel. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » Acute DiseaseAgedAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Murine-DerivedAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useHepatitis B/etiologyHepatitis B Antibodies/bloodHepatitis B Surface Antigens/bloodHepatitis B Surface Antigens/immunologyHumansLymphoma, Follicular/complicationsLymphoma, Follicular/drug therapyMaleRecurrenceRituximab
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedAntineoplastic AgentsHepatitis B AntibodiesHepatitis B Surface AntigensRituximab
Year: 2001 PMID: 11187122 DOI: 10.1056/NEJM200101043440120
Source DB: PubMed Journal: N Engl J Med ISSN: 0028-4793 Impact factor: 91.245